Carregant...
Renal Effects of Sodium-Glucose Co-Transporter Inhibitors
Sodium-glucose co-transporter 2 (SGLT2) inhibitors immediately reduce the glomerular filtration rate (GFR) in patients with type 2 diabetes mellitus. When given chronically, they confer benefit by markedly slowing the rate at which chronic kidney disease progresses and are the first agents to do so...
Guardat en:
| Publicat a: | Am J Cardiol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7258222/ https://ncbi.nlm.nih.gov/pubmed/31741437 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2019.10.027 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|